A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
about
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.A sensitive liquid chromatography-mass spectrometry bioanalytical assay for a novel anticancer candidate--ZMC1.Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients.Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?Fluorescence properties and cellular distribution of the investigational anticancer drug triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(II) complex.Development of an LC-MS/MS method for analysis of interconvertible Z/E isomers of the novel anticancer agent, Bp4eT.Lipid accumulation in human breast cancer cells injured by iron depletors.
P2860
Q33388089-5440EDB9-BFCD-41D1-BB6C-43E0C11FCB74Q33827191-158EA7DD-384F-4F80-BB94-7102DF89ECC2Q34615592-6A4C5FB5-4855-4B09-827A-F4AB4DE13F83Q34685780-0A8BB9B6-DA2B-4053-8A4A-0BB2FE329562Q35222202-0ECC2D8E-8BB3-4332-A3E2-FD0A3A7C632CQ36112585-1456B7F2-569E-4B4E-A250-A23CC79574F6Q38831900-44B24B13-5354-45C2-936F-09FADC0A2254Q39380445-0EE913C6-954D-49D7-814D-DD73332D3DD0Q39753374-DB4A2EE6-5AF8-4135-9F39-F8ED66431DE1Q43176490-C2C95C3F-2681-4539-B1AB-B375DC111B42Q52690604-63BF366F-93C9-4470-ADFD-542AF7CED183
P2860
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A phase I study of Triapine in ...... ts with advanced solid tumors.
@ast
A phase I study of Triapine in ...... ts with advanced solid tumors.
@en
type
label
A phase I study of Triapine in ...... ts with advanced solid tumors.
@ast
A phase I study of Triapine in ...... ts with advanced solid tumors.
@en
prefLabel
A phase I study of Triapine in ...... ts with advanced solid tumors.
@ast
A phase I study of Triapine in ...... ts with advanced solid tumors.
@en
P2093
P2860
P1476
A phase I study of Triapine in ...... ts with advanced solid tumors.
@en
P2093
Anne M Traynor
Dona Alberti
Jens Eickhoff
Jill M Kolesar
Marcia Pomplun
Rebecca Marnocha
Sherry Morgan-Meadows
P2860
P2888
P304
P356
10.1007/S00280-008-0890-8
P577
2008-12-13T00:00:00Z
P5875
P6179
1017352047